The Video Journal of Hematology and Hematological Oncology / X
Jul 19, 2025, 19:00
Steven Treon on Promising Advances: 3 Novel Therapies Transforming Waldenström’s Macroglobulinemia
The Video Journal of Hematology and Hematological Oncology shared a post on X:
”What are some of the most exciting developments in the field of Waldenström’s macroglobulinemia? We caught up with Steven Treon of Dana-Farber Cancer Institute at 18 ICML to find out!”
Watch the interview here.
Dr. Steven Treon highlights promising advances in Waldenström’s macroglobulinemia, focusing on novel therapies like BTK degraders, that demonstrate strong efficacy, even in resistant cases, as well as non-covalent BTK inhibitors and BCL2 inhibitors.
His insights were shared at the 18th International Conference on Malignant Lymphoma in Lugano.
Latest scientific advancements in hematology highlighted in Hemostasis Today.
-
Aug 22, 2026, 07:45Ziad Hijazi: Refining Risk Assessment in Atrial Fibrillation Without Oral Anticoagulation
-
Aug 22, 2026, 07:35Archil Jaliashvili: The Real Battle Is Not About Blood Volume — It Is About Oxygen
-
Aug 21, 2026, 21:58Toby Richards: WEHI Trial Solidifies IV Iron as Third-Trimester Standard
-
Aug 21, 2026, 21:51Mehak Trehan: From Reading the Chapter to Writing One
-
Aug 21, 2026, 21:38Ann Reilly: Navigating Postoperative vs. Acute Blood Loss Anemia – A CDI Case Study
-
Aug 21, 2026, 21:29Merlin Crossley: Atomic Precision in Sickle Cell Care – Structural Targeting for Fetal Globin Reactivation
-
Aug 21, 2026, 19:09Aphisit Thongthaisin: Admitted to Sorbonne University’s T2H University Diploma for 2026/2027
-
Aug 21, 2026, 19:07José Luis Ferreiro Gutiérrez: Proud to Be Elected Chairperson-Elect of the ESC Working Group on Thrombosis
-
Aug 21, 2026, 19:00Manuel Monreal: New RIETE Registry Data on VTE Recurrence and Bleeding During Anticoagulation